[{"AccountsPayableCurrent_0_Q1_USD":6623000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":178829000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":478347000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q1_USD":497000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":497000.0,"AccruedRoyaltiesCurrent_0_Q1_USD":3776000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-87000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":2989000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":3237000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":16030000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":22348000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":2215000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":2000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-18000.0,"OtherExpenses_1_Q1_USD":1497000.0,"InvestmentsFairValueDisclosure_0_Q1_USD":630042000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_0_Q1_USD":114580000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue_0_Q1_USD":114580000.0,"PaymentsToAcquireAvailableForSaleSecurities_1_Q1_USD":100773000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":1226000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":2423000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":1228000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-86795000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":2428987000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-15638000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q1_Security":21.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1_Q1_USD":2000.0,"EquitySecuritiesFvNi_0_Q1_USD":478347000.0,"RestrictedCashNoncurrent_0_Q1_USD":5770000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":131315000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.08,"OperatingLeaseRightOfUseAsset_0_Q1_USD":8613000.0,"OperatingLeasePayments_1_Q1_USD":1291000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":6090000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":2909000.0,"OperatingLeaseLiability_0_Q1_USD":8999000.0,"OperatingLeaseCost_1_Q1_USD":1487000.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_1_Q1_USD":1269000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":1656000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":4678000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":2338000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":2179000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":1317000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":1090000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":1011000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":10655000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":988000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":2907000.0,"InterestReceivableCurrent_0_Q1_USD":2935000.0,"IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_1_Q1_USD":842000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":1100000.0,"EquitySecuritiesFvNiCost_0_Q1_USD":476850000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":2720000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":90068000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":24057000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":1100000.0,"NetIncomeLoss_1_Q1_USD":-88023000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-49002000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":29608000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":3754000.0,"LiabilitiesCurrent_0_Q1_USD":99741000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":747450000.0,"Liabilities_0_Q1_USD":109068000.0,"InventoryNet_0_Q1_USD":6318000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":5855000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-599000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-88023000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.57,"Depreciation_1_Q1_USD":294000.0,"CostsAndExpenses_1_Q1_USD":179583000.0,"CommonStockValue_0_Q1_USD":15000.0,"CommonStockSharesOutstanding_0_Q1_shares":155441052.0,"CommonStockSharesIssued_0_Q1_shares":155441052.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":173059000.0,"AssetsCurrent_0_Q1_USD":724421000.0,"Assets_0_Q1_USD":747450000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":21064000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":1525000.0,"AccountsReceivableNetCurrent_0_Q1_USD":41636000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":934000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":3754000.0,"ProfitLoss_1_Q1_USD":-88023000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":5089000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":2799000.0,"PrepaidExpenseCurrent_0_Q1_USD":22126000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":21711000.0,"GainLossOnInvestments_1_Q1_USD":-1497000.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":3520000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":376000.0,"IncreaseDecreaseInInventories_1_Q1_USD":37000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":370000.0,"ShareBasedCompensation_1_Q1_USD":22348000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":101973000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":72636000.0,"OtherAssetsNoncurrent_0_Q1_USD":1342000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"OperatingIncomeLoss_1_Q1_USD":-89515000.0,"CommonStockSharesAuthorized_0_Q1_shares":225000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":93118000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":155368000.0,"StockholdersEquity_0_Q1_USD":638382000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1792145000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":276000.0,"Ticker":"ACAD","CIK":"1070494","name":"ACADIA PHARMACEUTICALS INC","OfficialName":"ACADIA Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3501345407.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200508"}]